FDA Denies Square Pharmaceuticals’ Petition to Revise GDUFA Facility Fees

Drug Industry Daily
The Generic Drug User Fee Amendments of 2012 do not allow for a waiver, reduction nor postponement of finished dosage form (FDF) facility fees for small and/or foreign businesses, the FDA says in a letter denying Square Pharmaceuticals’ citizen petition requesting a waiver and change to GDUFA’s statutory language.

To View This Article:


Subscribe To Drug Industry Daily